Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 261

1.

Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.

Tucker CA, Bebb G, Klasa RJ, Chhanabhai M, Lestou V, Horsman DE, Gascoyne RD, Wiestner A, Masin D, Bally M, Williams ME.

Leuk Res. 2006 Apr;30(4):449-57. Epub 2005 Sep 23.

PMID:
16183118
2.

Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.

Dreyling MH, Bullinger L, Ott G, Stilgenbauer S, Müller-Hermelink HK, Bentz M, Hiddemann W, Döhner H.

Cancer Res. 1997 Oct 15;57(20):4608-14.

3.

A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas.

Belaud-Rotureau MA, Parrens M, Dubus P, Garroste JC, de Mascarel A, Merlio JP.

Mod Pathol. 2002 May;15(5):517-25.

4.

Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry.

Hui P, Howe JG, Crouch J, Nimmakayalu M, Qumsiyeh MB, Tallini G, Flynn SD, Smith BR.

Leuk Lymphoma. 2003 Aug;44(8):1385-94.

PMID:
12952233
5.

Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization.

Kodet R, Mrhalová M, Krsková L, Soukup J, Campr V, Neskudla T, Szépe P, Plank L.

Virchows Arch. 2003 Jun;442(6):538-47. Epub 2003 May 1.

PMID:
12728315
6.

Establishment and characterization of a new mantle cell lymphoma cell line, Mino.

Lai R, McDonnell TJ, O'Connor SL, Medeiros LJ, Oudat R, Keating M, Morgan MB, Curiel TJ, Ford RJ.

Leuk Res. 2002 Sep;26(9):849-55.

PMID:
12127561
7.

Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.

Specht K, Kremer M, Müller U, Dirnhofer S, Rosemann M, Höfler H, Quintanilla-Martinez L, Fend F.

Clin Cancer Res. 2002 Sep;8(9):2902-11.

8.

Complex analysis of cyclin D1 expression in mantle cell lymphoma: two cyclin D1-negative cases detected.

Stefancikova L, Moulis M, Fabian P, Falkova I, Vasova I, Kren L, Macak J, Smardova J.

J Clin Pathol. 2009 Oct;62(10):948-50. doi: 10.1136/jcp.2008.063701.

PMID:
19783727
9.

Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.

Yatabe Y, Suzuki R, Tobinai K, Matsuno Y, Ichinohasama R, Okamoto M, Yamaguchi M, Tamaru J, Uike N, Hashimoto Y, Morishima Y, Suchi T, Seto M, Nakamura S.

Blood. 2000 Apr 1;95(7):2253-61.

10.

Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma.

de Boer CJ, van Krieken JH, Kluin-Nelemans HC, Kluin PM, Schuuring E.

Oncogene. 1995 May 4;10(9):1833-40.

PMID:
7753558
11.

In situ hybridization and reverse transcription-polymerase chain reaction for cyclin D1 mRNA in the diagnosis of mantle cell lymphoma in paraffin-embedded tissues.

Athanasiou E, Kotoula V, Hytiroglou P, Kouidou S, Kaloutsi V, Papadimitriou CS.

Mod Pathol. 2001 Feb;14(2):62-71.

12.

Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.

Wlodarska I, Dierickx D, Vanhentenrijk V, Van Roosbroeck K, Pospísilová H, Minnei F, Verhoef G, Thomas J, Vandenberghe P, De Wolf-Peeters C.

Blood. 2008 Jun 15;111(12):5683-90. doi: 10.1182/blood-2007-10-118794. Epub 2008 Apr 7.

13.

Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.

Fu K, Weisenburger DD, Greiner TC, Dave S, Wright G, Rosenwald A, Chiorazzi M, Iqbal J, Gesk S, Siebert R, De Jong D, Jaffe ES, Wilson WH, Delabie J, Ott G, Dave BJ, Sanger WG, Smith LM, Rimsza L, Braziel RM, Müller-Hermelink HK, Campo E, Gascoyne RD, Staudt LM, Chan WC; Lymphoma/Leukemia Molecular Profiling Project.

Blood. 2005 Dec 15;106(13):4315-21. Epub 2005 Aug 25.

14.

Real-time RT-PCR assay for quantifying cyclin D1 mRNA in B-cell non-Hodgkin's lymphomas.

Medeiros LJ, Hai S, Thomazy VA, Estalilla OC, Romaguera J, Luthra R.

Mod Pathol. 2002 May;15(5):556-64.

15.

Nuclear expression of sox11 is highly associated with mantle cell lymphoma but is independent of t(11;14)(q13;q32) in non-mantle cell B-cell neoplasms.

Chen YH, Gao J, Fan G, Peterson LC.

Mod Pathol. 2010 Jan;23(1):105-12. doi: 10.1038/modpathol.2009.140. Epub 2009 Oct 2.

16.

Cyclin D1 positive multiple myeloma: predominance of the short, 3'UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions.

Slotta-Huspenina J, Koch I, Richter M, Bink K, Kremer M, Specht K, Krugmann J, Quintanilla-Martinez L, Fend F.

Leuk Res. 2008 Jan;32(1):79-88. Epub 2007 Jul 16.

PMID:
17629555
17.

A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation.

Yufu Y, Goto T, Choi I, Uike N, Kozuru M, Ohshima K, Taniguchi T, Motokura T, Yatabe Y, Nakamura S.

Cancer. 1999 Apr 15;85(8):1750-7.

PMID:
10223569
18.

Cyclin D1 expression in patients with multiple myeloma.

Troussard X, Avet-Loiseau H, Macro M, Mellerin MP, Malet M, Roussel M, Sola B.

Hematol J. 2000;1(3):181-5.

PMID:
11920187
20.

Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2.

Chuang SS, Huang WT, Hsieh PP, Tseng HH, Campo E, Colomer D, Ye H, Lu CL, Chang HM, Cho CY, Huang SH, Lu YC, Wu JD.

Pathol Int. 2006 Aug;56(8):440-8.

PMID:
16872438
Items per page

Supplemental Content

Write to the Help Desk